IL49238A - O-aminoethyl trifluoromethyl-phenyl-ketoximes, their preparation and pharmaceutical compositions containing them - Google Patents

O-aminoethyl trifluoromethyl-phenyl-ketoximes, their preparation and pharmaceutical compositions containing them

Info

Publication number
IL49238A
IL49238A IL49238A IL4923876A IL49238A IL 49238 A IL49238 A IL 49238A IL 49238 A IL49238 A IL 49238A IL 4923876 A IL4923876 A IL 4923876A IL 49238 A IL49238 A IL 49238A
Authority
IL
Israel
Prior art keywords
ketoximes
aminoethyl
trifluoromethyl
phenyl
preparation
Prior art date
Application number
IL49238A
Other languages
English (en)
Other versions
IL49238A0 (en
Original Assignee
Philips Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Nv filed Critical Philips Nv
Publication of IL49238A0 publication Critical patent/IL49238A0/xx
Publication of IL49238A publication Critical patent/IL49238A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/50—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
    • C07C251/58—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/04—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
    • C07C249/08—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes by reaction of hydroxylamines with carbonyl compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL49238A 1975-03-20 1976-03-17 O-aminoethyl trifluoromethyl-phenyl-ketoximes, their preparation and pharmaceutical compositions containing them IL49238A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7503310A NL7503310A (nl) 1975-03-20 1975-03-20 Verbindingen met antidepressieve werking.

Publications (2)

Publication Number Publication Date
IL49238A0 IL49238A0 (en) 1976-05-31
IL49238A true IL49238A (en) 1978-08-31

Family

ID=19823424

Family Applications (1)

Application Number Title Priority Date Filing Date
IL49238A IL49238A (en) 1975-03-20 1976-03-17 O-aminoethyl trifluoromethyl-phenyl-ketoximes, their preparation and pharmaceutical compositions containing them

Country Status (27)

Country Link
US (1) US4085225A (OSRAM)
JP (1) JPS6026776B2 (OSRAM)
AR (2) AR211011A1 (OSRAM)
AT (1) AT340895B (OSRAM)
AU (1) AU505358B2 (OSRAM)
BE (1) BE839744A (OSRAM)
CA (1) CA1076142A (OSRAM)
CH (4) CH626057A5 (OSRAM)
DD (1) DD128332A5 (OSRAM)
DE (1) DE2610886A1 (OSRAM)
DK (1) DK144942C (OSRAM)
ES (1) ES446192A1 (OSRAM)
FI (1) FI61875C (OSRAM)
FR (1) FR2304336A1 (OSRAM)
GB (1) GB1535226A (OSRAM)
GR (1) GR60052B (OSRAM)
HU (1) HU171030B (OSRAM)
IE (1) IE43768B1 (OSRAM)
IL (1) IL49238A (OSRAM)
IT (1) IT1063064B (OSRAM)
MX (1) MX9203723A (OSRAM)
NL (1) NL7503310A (OSRAM)
PL (3) PL100614B1 (OSRAM)
SE (1) SE410312B (OSRAM)
SU (3) SU635867A3 (OSRAM)
YU (1) YU39345B (OSRAM)
ZA (1) ZA761434B (OSRAM)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1110460B (it) * 1977-03-02 1985-12-23 Ciba Geigy Ag Prodotti che favoriscono la crescita delle piante e prodotti che proteggono le piante a base di eteri di ossime e di esteri di ossime loro preparazione e loro impiego
FR2639942B1 (fr) * 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
US5665756A (en) * 1994-08-03 1997-09-09 Hoechst Marion Roussel, Inc. Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders
US6548084B2 (en) * 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
AU6776196A (en) * 1995-08-16 1997-03-12 Eli Lilly And Company Potentiation of serotonin response
IN182588B (OSRAM) 1998-05-12 1999-05-08 Sun Pharmaceutical Ind Ltd
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
IN186677B (OSRAM) 1999-11-12 2001-10-20 Sun Pharmaceutical Ind Ltd
AU5702201A (en) * 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
US20080021085A1 (en) * 2000-04-13 2008-01-24 Mayo Foundation For Medical Education And Research Method of reducing abeta42 and treating diseases
WO2001080845A2 (en) * 2000-04-24 2001-11-01 Aryx Therapeutics (2-aminoethyl) oxime derivatives for the treatment of depression
US7256191B2 (en) * 2000-04-24 2007-08-14 Aryx Therapeutics Materials and methods for the treatment of depression
CN101921267A (zh) * 2001-10-12 2010-12-22 阿泽范药品公司 β-内酰胺后叶加压素V1a拮抗剂
CA2477088A1 (en) 2002-02-22 2003-10-02 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
WO2004071431A2 (en) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Method and composition for treating neurodegenerative disorders
AU2004311577A1 (en) * 2003-07-11 2005-07-21 Myriad Genetics, Inc. Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease
CA2537402C (en) 2003-09-12 2009-05-05 Pfizer Inc. Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors
WO2005051919A1 (en) * 2003-11-26 2005-06-09 Pfizer Products Inc. Aminopyrazole derivatives as gsk-3 inhibitors
PL1691811T3 (pl) 2003-12-11 2014-12-31 Sunovion Pharmaceuticals Inc Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji
US20070293538A1 (en) * 2004-04-13 2007-12-20 Myriad Genetics, Incorporated Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
EP1737473A4 (en) * 2004-04-19 2009-08-26 Noven Therapeutics Llc COMBINATIONS OF LITHIUM AND USES THEREOF
US20050252144A1 (en) * 2004-04-29 2005-11-17 Macdonald Robert A Veneers for walls, retaining walls and the like
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020853A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
US9597314B2 (en) 2005-03-22 2017-03-21 Azevan Pharmaceuticals, Inc. Beta-lactamylalkanoic acids for treating premenstrual disorders
CN101163689A (zh) * 2005-04-22 2008-04-16 惠氏公司 {[(2r)-7-(2，6-二氯苯基)-5-氟-2，3-二氢-1-苯并呋喃-2-基]甲基}胺盐酸盐的晶形
CA2604916A1 (en) 2005-04-22 2006-11-02 Wyeth Dihydrobenzofuran derivatives and uses thereof
TW200719886A (en) * 2005-04-22 2007-06-01 Wyeth Corp Dihydrobenzofuran derivatives and uses thereof
CA2605554A1 (en) * 2005-04-22 2006-11-02 Wyeth Benzofuranyl alkanamine derivatives and uses thereof as 5-ht2c agonists
WO2007008758A2 (en) 2005-07-08 2007-01-18 Braincells, Inc. Methods for identifying agents and conditions that modulate neurogenesis
US20070015832A1 (en) * 2005-07-14 2007-01-18 Myriad Genetics, Incorporated Methods of treating overactive bladder and urinary incontinence
US8048874B2 (en) 2005-07-19 2011-11-01 Azevan Pharmaceuticals, Inc. Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
NZ564789A (en) * 2005-07-22 2010-07-30 Myriad Genetics Inc High drug load formulations and dosage forms
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス，インコーポレイティド Ｐｄｅ阻害による神経新生の調節
WO2007053596A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
FR2912057B1 (fr) * 2007-02-07 2009-04-17 Sanofi Aventis Sa Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
KR20080105104A (ko) * 2006-03-24 2008-12-03 와이어쓰 우울증 치료를 위한 신규한 치료학적 병용제
JP4615470B2 (ja) * 2006-03-29 2011-01-19 卓郎 簑和田 大脳の認知力を用いた疾患治療・予防の方法および医薬
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
WO2007134136A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
EP2026813A2 (en) 2006-05-09 2009-02-25 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2046119A2 (en) * 2006-07-07 2009-04-15 Myriad Genetics, Inc. Treatment of psychiatric disorders
TW200817003A (en) * 2006-07-31 2008-04-16 Sanofi Aventis Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor
WO2008030651A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100016274A1 (en) * 2006-09-14 2010-01-21 Koppel Gary A Beta-lactam cannabinoid receptor modulators
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20080167363A1 (en) * 2006-12-28 2008-07-10 Braincells, Inc Modulation of Neurogenesis By Melatoninergic Agents
CA2675132A1 (en) * 2007-01-11 2008-07-17 Braincells, Inc. Modulation of neurogenesis with use of modafinil
WO2009128058A1 (en) 2008-04-18 2009-10-22 UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al Psycho-pharmaceuticals
US20100092479A1 (en) * 2008-08-18 2010-04-15 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
SI2491038T1 (sl) 2009-10-23 2016-08-31 Janssen Pharmaceutica N.V. Disubstituirani oktahil-dropirolo(3,4-c)piroli kot modulatorji oreksinskega receptorja
CA2783699C (en) 2009-12-08 2019-01-15 Case Western Reserve University Primary amine compounds for treating ocular disorders
ES2662350T3 (es) 2010-07-01 2018-04-06 Azevan Pharmaceuticals, Inc. Procedimientos para el tratamiento del trastorno por estrés postraumático
EP2685966A1 (en) 2011-03-17 2014-01-22 Lupin Limited Controlled release pharmaceutical compositions of selective serotonin reuptake inhibitor
KR101427221B1 (ko) * 2012-08-29 2014-08-13 주식회사 에스텍파마 플루복사민 자유 염기의 정제방법 및 이를 이용한 고순도 플루복사민 말레이트의 제조방법
PT2981518T (pt) * 2013-04-03 2021-06-04 Zcl Chemicals Ltd Um processo melhorado para a preparação de maleato de fluvoxamina
PL3104847T3 (pl) 2014-02-07 2021-07-05 Támogatott Kutatócsoportok Irodája Nowe zastosowanie związków agonistycznych receptora sigma-1
MX382453B (es) 2014-03-28 2025-03-13 Azevan Pharmaceuticals Inc Composiciones y metodos para tratar enfermedades neurodegenerativas
PH12018501903B1 (en) 2016-03-10 2023-03-17 Janssen Pharmaceutica Nv Methods of treating depression using orexin-2 receptor antagonists
US12239125B2 (en) 2016-11-24 2025-03-04 SigmaDrugs Kutató Korlátolt Felelsség Társaság Compositions for organ preservation
CN111295373B (zh) 2017-09-15 2024-12-10 阿泽凡药物公司 用于治疗脑损伤的组合物和方法
WO2021016112A2 (en) 2019-07-19 2021-01-28 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3692835A (en) * 1967-04-05 1972-09-19 Jan Van Dijk Pharmacologically active amino-ethyl oximes

Also Published As

Publication number Publication date
AU505358B2 (en) 1979-11-15
DK144942B (da) 1982-07-12
NL7503310A (nl) 1976-09-22
YU39345B (en) 1984-10-31
JPS51125345A (en) 1976-11-01
AR211153A1 (es) 1977-10-31
SU645559A3 (ru) 1979-01-30
IE43768L (en) 1976-09-20
FI760699A7 (OSRAM) 1976-09-21
AR211011A1 (es) 1977-10-14
AU1214776A (en) 1977-09-22
DE2610886A1 (de) 1976-10-07
MX9203723A (es) 1992-07-01
SE410312B (sv) 1979-10-08
FR2304336B1 (OSRAM) 1979-09-28
DD128332A5 (de) 1977-11-09
PL100614B1 (pl) 1978-10-31
US4085225A (en) 1978-04-18
IT1063064B (it) 1985-02-11
SE7603341L (sv) 1976-09-21
AT340895B (de) 1978-01-10
FI61875C (fi) 1982-10-11
CH629477A5 (de) 1982-04-30
SU620206A3 (ru) 1978-08-15
FI61875B (fi) 1982-06-30
YU71476A (en) 1982-10-31
CH629761A5 (de) 1982-05-14
FR2304336A1 (fr) 1976-10-15
ATA195476A (de) 1977-05-15
JPS6026776B2 (ja) 1985-06-25
HU171030B (hu) 1977-10-28
IE43768B1 (en) 1981-05-20
DK144942C (da) 1982-12-06
SU635867A3 (ru) 1978-11-30
GR60052B (en) 1978-04-04
ES446192A1 (es) 1977-10-01
IL49238A0 (en) 1976-05-31
PL100052B1 (pl) 1978-08-31
CH626057A5 (OSRAM) 1981-10-30
CA1076142A (en) 1980-04-22
ZA761434B (en) 1977-10-26
PL101951B1 (pl) 1979-02-28
CH629184A5 (de) 1982-04-15
DK115976A (da) 1976-09-21
DE2610886C2 (OSRAM) 1987-09-24
BE839744A (fr) 1976-09-20
GB1535226A (en) 1978-12-13

Similar Documents

Publication Publication Date Title
IL49238A (en) O-aminoethyl trifluoromethyl-phenyl-ketoximes, their preparation and pharmaceutical compositions containing them
IL50632A (en) Pyridinyl-2(1h)-pyridinones,their preparation and pharmaceutical compositions containing them
IL50176A0 (en) Novel tetrahydroisoquinoline derivatives,their preparation and pharmaceutical compositions containing them
IL48835A0 (en) New peptides,their preparation and pharmaceutical compositions containing them
IL50815A0 (en) New aminobenzoamides their preparation and pharmaceutical compositions containing them
IL49911A0 (en) New 5-aroylpyrrole derivatives,their preparation and pharmaceutical compositions containing them
IL50047A0 (en) Novel peptides,their preparation and pharmaceutical compositions containing them
IL50631A0 (en) 1-benzazolylalkyl-4-substituted-piperidines,their preparation and pharmaceutical compositions containing them
IL50690A0 (en) Novel benzisothiazole derivatives,their preparation and pharmaceutical compositions containing them
IL50869A (en) Heterocyclylthio-ethylimidazole derivatives,their preparation and pharmaceutical compositions containing them
IL49424A0 (en) 1,1,1-triaryl-alkylamines,their preparation and pharmaceutical compositions containing them
IL49788A0 (en) 11-desoxy-16-aryloxy-omega-pentanorprostaglandins,their preparation and pharmaceutical compositions containing them
IL49280A0 (en) Novel benzophenones,their preparation and pharmaceutical compositions containing them
IL50335A (en) Diphenylalkylpolyamine derivatives,their preparation and pharmaceutical compositions containing them
IL49991A (en) L-pyroglutamyl-l-prolinamide, its preparation and pharmaceutical compositions containing it
IL49132A (en) 16,1l-disubstituted androst-4-en-3-ones,their preparation and pharmaceutical compositions containing them
IL50156A (en) N,n-bis-isoquinolinoalkylamine derivatives, their preparation and pharmaceutical compositions containing them
IL50797A0 (en) New penicillins,their preparation and pharmaceutical compositions containing them
IL49099A (en) Xanthene-9-carboxylates, their preparation and pharmaceutical compositions containing them
IL49971A0 (en) New 2-benzoypranone derivatives,their preparation and pharmaceutical compositions containing them
IL48788A0 (en) New penicillins,their preparation and pharmaceutical compositions containing them
IL50554A (en) 2,9-dioxatricyclodecanes,their preparation and pharmaceutical compositions containing them
IL49847A0 (en) New penicillins,their preparation and pharmaceutical compositions containing them
IL49239A (en) O-aminoethyl methylthiophenyl-ketoximes, their preparation and pharmaceutical compositions containing them
IL50090A0 (en) New quinolines,their preparation and pharmaceutical compositions containing them